Welcome to our dedicated page for DelphX Capital Markets news (Ticker: $DPXCF), a resource for investors and traders seeking the latest updates and insights on DelphX Capital Markets stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DelphX Capital Markets's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DelphX Capital Markets's position in the market.
DelphX Capital Markets has engaged ICP Securities for automated market making services, utilizing ICP's proprietary algorithm, ICP Premium™, compliant with TSX Venture Exchange and other regulations. ICP will receive C$7,500 monthly, paid in advance. The agreement covers an initial four-month term, with automatic monthly renewals unless a 30-day notice is provided. No performance factors, stock options, or other compensation are included. ICP's activities aim to correct imbalances in the supply and demand of DelphX shares, and it will bear its own trading costs. ICP is an arm's length party specializing in liquidity provision and automated market making, established in 2023.
